Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biodel: Upside from Potential Linjeta Approval
Seeking Alpha
Friday, October 1, 2010 - 12:14pm
tags:
Linjeta, Biodel, diabetes, insulin
Chief Justice Roberts Sold Pfizer. Should You?
Motley Fool
Friday, October 1, 2010 - 12:13pm
tags:
Pfizer
Biosante: Key Catalysts Should Renew Investor Interest
Seeking Alpha
Friday, October 1, 2010 - 10:16am
tags:
BioSante, LibiGel, female sexual dysfunction
[video] What J&J's CEO didn't say
CNN Money
Friday, October 1, 2010 - 10:13am
tags:
JNJ, William Weldon, recalls
Sanofi, Merck Said to Ready Sale of $1 Billion of Animal-Health Operations
Bloomberg
Friday, October 1, 2010 - 10:11am
tags:
Merck, Sanofi, animal health, M&A, Pfizer, Bayer, Boehringer Ingelheim, Eli Lilly, Novartis
Drugmaker Deal Tied to Health Law Provides $2 Billion
Bloomberg
Friday, October 1, 2010 - 10:09am
tags:
Pfizer, Bristol-Myers Squibb, AstraZeneca, healthcare reform
Is Teva Pharmaceutical 's Cash Flow Just For Show?
Motley Fool
Friday, October 1, 2010 - 6:54am
tags:
Teva Pharmaceuticals
Merck to appeal $4.6M verdict in Mass. fraud case
Yahoo/AP
Friday, October 1, 2010 - 6:34am
tags:
Merck, Massachusetts, fraud, Schering Plough, albuterol
AstraZeneca to Start Long-Term Brilinta Heart Attack Study
Bloomberg
Friday, October 1, 2010 - 6:32am
tags:
AstraZeneca, heart attacks, Brilinta, blood thinners
J&J Shares Dip on Capitol Hill Grilling
Barron's
Thursday, September 30, 2010 - 3:47pm
tags:
JNJ, recalls
Bristol-Myers' Delayed Steal
Motley Fool
Thursday, September 30, 2010 - 3:46pm
tags:
Bristol-Myers Squibb, ZymoGenetics, M&A
Novartis to pay $422.5 million settlement
Marketwatch
Thursday, September 30, 2010 - 3:46pm
tags:
Novartis, settlements, off-label, Trileptal, kickbacks
FDA exec: agency too slow to order J&J recall
Yahoo/AP
Thursday, September 30, 2010 - 11:31am
tags:
FDA, JNJ, recalls
Report: Big jump in brand-name drugs available to Medicare seniors next year
The Hill
Thursday, September 30, 2010 - 11:30am
tags:
Medicare
The Shocking Truth About Free Lunches And Pens
Pharmalot
Thursday, September 30, 2010 - 11:27am
tags:
drug reps, physicians, physician gifts
Will Generic Lipitor Be Delayed?
Forbes
Thursday, September 30, 2010 - 11:25am
tags:
Pfizer, Lipitor, generics
Amgen Drug May Block Some Breast Cancer, Studies Hint
Bloomberg
Thursday, September 30, 2010 - 11:24am
tags:
Amgen, breast cancer, denosumab
Dendreon in Neutral Lane
Yahoo/Zacks.com
Thursday, September 30, 2010 - 11:23am
tags:
Dendreon, Provenge
Glaxo Herpes Vaccine For Women Is A Bust
Pharmalot
Thursday, September 30, 2010 - 11:10am
tags:
GSK, herpes, vaccines, Simplirix
Santarus says colitis drug met goal in study
Yahoo/AP
Thursday, September 30, 2010 - 11:09am
tags:
Santarus, ulcerative colitis, Budesonide MMX

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.